Surgery Partners (NASDAQ:SGRY) Stock Rating Cut to “Hold” at TD Cowen

Surgery Partners (NASDAQ:SGRY) was downgraded by stock analysts at TD Cowen from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks reports.

SGRY has been the subject of several other reports. UBS Group cut Surgery Partners from a “buy” rating to a “hold” rating and upped their price objective for the stock from $21.00 to $23.50 in a research report on Wednesday, October 28th. Royal Bank Of Canada lowered Surgery Partners from a “moderate buy” rating to a “hold” rating and set a $23.50 target price on the stock. in a research report on Monday, October 26th. JPMorgan Chase & Co. boosted their target price on Surgery Partners from $14.00 to $15.00 and gave the stock a “neutral” rating in a research note on Monday, September 14th. Zacks Research downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. Finally, Cantor Fitzgerald lowered shares of Surgery Partners from an “overweight” rating to a “hold” rating in a research note on Monday, October 26th. Three research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $20.14.

Surgery Partners Price Performance

Shares of SGRY opened at $23.12 on Friday. The company has a market cap of $3.03 billion, a P/E ratio of -33.03, a PEG ratio of 7.19 and a beta of 1.90. Surgery Partners has a fifty-two week low of $11.41 and a fifty-two week high of $23.37. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. The firm’s 50 day moving average price is $15.30 and its 200 day moving average price is $14.68.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.06 by $0.04. The business had revenue of $848.90 million during the quarter, compared to the consensus estimate of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.17 earnings per share. On average, research analysts forecast that Surgery Partners will post 0.25 earnings per share for the current fiscal year.

Insider Buying and Selling at Surgery Partners

In other news, Director Teresa DeLuca bought 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was purchased at an average cost of $14.35 per share, with a total value of $143,500.00. Following the transaction, the director directly owned 66,843 shares in the company, valued at $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Surgery Partners

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Jupiter Topco LLC acquired a new position in Surgery Partners in the 2nd quarter valued at about $233,220,000. Pentwater Capital Management LP acquired a new stake in Surgery Partners in the second quarter valued at $195,384,000. BlackRock Inc. purchased a new stake in shares of Surgery Partners during the 2nd quarter worth $104,857,000. Dimensional Fund Advisors LP boosted its position in shares of Surgery Partners by 7.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company’s stock worth $63,131,000 after purchasing an additional 389,831 shares in the last quarter. Finally, Hsbc Holdings PLC acquired a new position in shares of Surgery Partners during the 2nd quarter worth $48,912,000.

Key Surgery Partners News

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: Bon Secours Mercy Health’s proposed $23.50-per-share acquisition provides a clear valuation reference and supports the share price. Bain Capital, Surgery Partners’ largest shareholder, plans to roll its equity into the combined company, signaling substantial shareholder participation. Surgery Partners stock enters take-private focus after HealthSpan deal
• Neutral Sentiment: The consensus price target was raised 15.45% to $22.61, reflecting improved valuation expectations, but the target is below the merger offer and therefore provides limited incremental support while the transaction remains pending. Surgery Partners consensus price target increased by 15.45% to $22.61
• Negative Sentiment: KeyCorp reduced its FY2026 EPS forecast to $0.07 from $0.16 and cut its FY2027 forecast to a $0.21-per-share loss from expected earnings of $0.13. It also lowered its Q3 2026 estimate to a $0.13 loss, while forecasting a $0.08 loss for Q4. These revisions point to weaker near-term profitability than previously expected.
• Negative Sentiment: Multiple law firms are investigating the $23.50 merger, including whether Surgery Partners’ directors breached fiduciary duties and whether the transaction adequately serves shareholders. Such investigations may increase deal uncertainty, although these notices do not by themselves indicate that wrongdoing occurred. SGRY shareholder merger investigation Scott+Scott Surgery Partners investor alert

Surgery Partners Company Profile

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.